{"id":92805,"date":"2026-01-19T23:25:08","date_gmt":"2026-01-19T22:25:08","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?post_type=customer-stories&#038;p=92805"},"modified":"2026-03-02T10:07:19","modified_gmt":"2026-03-02T09:07:19","slug":"italfarmaco-accelerating-rare-disease-launch-with-vault-crm","status":"publish","type":"customer-stories","link":"https:\/\/www.veeva.com\/eu\/customer-stories\/italfarmaco-accelerating-rare-disease-launch-with-vault-crm\/","title":{"rendered":"Italfarmaco"},"content":{"rendered":"<p>Simona Gay, <a href=\"\/eu\/events\/commercial-summit-europe\/heroes\/\">2025 ³Ô¹Ï±¬ÁÏ Hero<\/a>, shares the challenge of launching a new rare disease division and a groundbreaking product across Europe and how it required them to establish a strong operational foundation quickly. The company selected ³Ô¹Ï±¬ÁÏ as a strategic partner to deploy commercial and medical operations on a single, unified platform.<\/p>\n<h2> Launching a new division in record time<\/h2>\n<p>\nEntering a complex, highly specialized market required speed and accuracy. The primary challenge for Italfarmaco was implementing core systems across multiple European countries, balancing standardization for efficiency with the need for country-specific personalization to meet local legislative requirements.<\/p>\n<h2>Unified commercial and medical operations<\/h2>\n<p>\nItalfarmaco adopted ³Ô¹Ï±¬ÁÏ Vault CRM to enable rapid, scalable launches across Europe. By unifying the commercial and medical teams on a single platform, the company achieved a complete, 360-degree view of the customer journey. This unified data model allows for real-time engagement measurement\u2014including digital interactions like email opens and website visits\u2014all in one system.<\/p>\n<h2>Foundation for growth and future innovation<\/h2>\n<p>The unified platform has laid the groundwork for future growth, allowing Italfarmaco to drive new strategies and make decisions based on high-quality data. Looking ahead, the company anticipates significant benefits from AI embedded in the system and achieving a perfectly integrated, measurable omnichannel strategy.<\/p>\n<p><a href=\"\/eu\/launch-excellence-pharma\/\">Achieve launch excellence<\/a> with confidence and speed with Vault CRM.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Italfarmaco discusses the challenge of launching their new Rare Disease division and how they achieved rapid speed-to-market across Europe.<\/p>\n","protected":false},"featured_media":93438,"parent":0,"template":"","product-link-list":[1402,1403,1418,1422,1429,1430,1432,1437],"class_list":["post-92805","customer-stories","type-customer-stories","status-publish","has-post-thumbnail","hentry","product-link-list-veeva-crm-approved-email","product-link-list-veeva-crm-engage","product-link-list-veeva-etmf","product-link-list-veeva-link","product-link-list-veeva-medinquiry","product-link-list-veeva-network-mdm","product-link-list-veeva-opendata-clinical","product-link-list-veeva-promomats"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/customer-stories\/92805"}],"collection":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/customer-stories"}],"about":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/types\/customer-stories"}],"version-history":[{"count":1,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/customer-stories\/92805\/revisions"}],"predecessor-version":[{"id":93437,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/customer-stories\/92805\/revisions\/93437"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media\/93438"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=92805"}],"wp:term":[{"taxonomy":"product-link-list","embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/product-link-list?post=92805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}